Bcl-2 Polyclonal Antibody |
|||
ABP50758-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human, Monkey. This Bcl-2 antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of S70 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50759-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human, Mouse, Rat. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T69 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50759-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human, Mouse, Rat. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T69 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50759-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human, Mouse, Rat. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T69 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50760-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T56 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50760-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T56 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP50760-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Human. This Bcl-2 antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the non-phosphorylation site of T56 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP57481-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Mouse, Rat. This Bcl-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from Bcl-2 at AA range: 10-90 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP57481-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Mouse, Rat. This Bcl-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from Bcl-2 at AA range: 10-90 |
|||
Bcl-2 Polyclonal Antibody |
|||
ABP57481-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 from Mouse, Rat. This Bcl-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from Bcl-2 at AA range: 10-90 |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1757-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human/Monkey. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1757-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human/Monkey. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1758-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1758-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1759-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES1759-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES8474-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
ES8474-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 from Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 Polyclonal Antibody |
|||
40638-100ul | SAB | 100ul | 302.4 EUR |
Bcl-2 Polyclonal Antibody |
|||
40638-50ul | SAB | 50ul | 224.4 EUR |
Bcl-2 Polyclonal Antibody |
|||
40639-100ul | SAB | 100ul | 302.4 EUR |
Bcl-2 Polyclonal Antibody |
|||
40639-50ul | SAB | 50ul | 224.4 EUR |
Polyclonal Bcl-2 Antibody |
|||
APG02209G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Bcl-2 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Bcl-2 Antibody |
|||
APG02220G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Bcl-2 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Bcl-2 Antibody |
|||
APG02221G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Bcl-2 . This antibody is tested and proven to work in the following applications: |
|||
Bcl-2 Rabbit mAb |
|||
A19693 | Abclonal | 20 μL | 18 EUR |
Bcl-2 Rabbit mAb |
|||
A19693-100ul | Abclonal | 100 ul | 492 EUR |
Bcl-2 Rabbit mAb |
|||
A19693-200ul | Abclonal | 200 ul | 685.2 EUR |
Bcl-2 Rabbit mAb |
|||
A19693-20ul | Abclonal | 20 ul | 265.2 EUR |
Bcl-2 Rabbit mAb |
|||
A19693-50ul | Abclonal | 50 ul | 344.4 EUR |
Anti-Bcl-2 Rabbit Monoclonal Antibody |
|||
M00040-1 | BosterBio | 100ug/vial | 476.4 EUR |
Description: Rabbit Monoclonal Bcl-2 Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human. |
|||
Polyclonal BCL2 / Bcl-2 Antibody |
|||
APG02235G | Leading Biology | 0.05ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BCL2 / Bcl-2 . This antibody is tested and proven to work in the following applications: |
|||
Rabbit Anti Bcl-X Polyclonal Antibody |
|||
CPBT-66399RB | Creative Diagnostics | 0.1 ml | 858 EUR |
Rabbit Anti Bcl-2 Binding Component 3 Polyclonal Antibody |
|||
CPBT-66398RB | Creative Diagnostics | 0.1 mg | 696 EUR |
Rabbit BCL-2 ELISA Kit |
|||
ERTB0040 | Abclonal | 96Tests | 625.2 EUR |
Bcl-2 Antibody (Clone Bcl-2/100) |
|||
3195-100 | Biovision | each | 430.8 EUR |
Anti-Bcl-10 Monoclonal Antibody (Carmen-1) |
|||
M01616-2 | BosterBio | 100ug | 476.4 EUR |
Description: Rat Monoclonal Bcl-10 Antibody (Carmen-1). Validated in IHC, WB and tested in Human, Mouse. |
|||
Bcl-2 Antibody |
|||
AF4700 | Affbiotech | 200ul | 540 EUR |
Bcl-2 Antibody |
|||
AF6138 | Affbiotech | 100ul | 420 EUR |
Bcl-2 Antibody |
|||
AF6139 | Affbiotech | 200ul | 420 EUR |
Bcl-2 Antibody |
|||
AF0769 | Affbiotech | 200ul | 420 EUR |
Bcl-2 Antibody |
|||
48496-100ul | SAB | 100ul | 399.6 EUR |
Bcl-2 Antibody |
|||
48496-50ul | SAB | 50ul | 286.8 EUR |
Bcl-2 Antibody |
|||
48675-100ul | SAB | 100ul | 399.6 EUR |
Bcl-2 Antibody |
|||
48675-50ul | SAB | 50ul | 286.8 EUR |
Bcl-2 Antibody |
|||
49367-100ul | SAB | 100ul | 399.6 EUR |
Bcl-2 Antibody |
|||
49367-50ul | SAB | 50ul | 286.8 EUR |
Bcl-2 antibody |
|||
70R-13967 | Fitzgerald | 100 ug | 386.4 EUR |
Description: Affinity purified Mouse polyclonal Bcl-2 antibody |
|||
Bcl-2 Antibody |
|||
24245-100ul | SAB | 100ul | 468 EUR |
Bcl-2 Antibody |
|||
24246-100ul | SAB | 100ul | 468 EUR |
Bcl-2 antibody |
|||
10R-1187 | Fitzgerald | 100 ul | 379.2 EUR |
Description: Mouse monoclonal Bcl-2 antibody |
|||
Bcl-2 Antibody |
|||
3335-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Bcl-2 Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Bcl-2 is the founding member of a family of over 20 proteins that are critical regulators of apoptosis. These can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bcl-2 is an inner mitochondrial membrane protein that inhibits apoptosis. It is thought to act by interacting with pro-apoptotic Bcl-2 family members such as Bak and Bad. Overexpression of Bcl-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer. |
|||
Bcl-2 Antibody |
|||
3335-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Bcl-2 Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Bcl-2 is the founding member of a family of over 20 proteins that are critical regulators of apoptosis. These can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bcl-2 is an inner mitochondrial membrane protein that inhibits apoptosis. It is thought to act by interacting with pro-apoptotic Bcl-2 family members such as Bak and Bad. Overexpression of Bcl-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer. |
|||
Bcl-2 Antibody |
|||
3337-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Bcl-2 Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Bcl-2 is the founding member of a family of over 20 proteins that are critical regulators of apoptosis. These can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bcl-2 is an inner mitochondrial membrane protein that inhibits apoptosis. It is thought to act by interacting with pro-apoptotic Bcl-2 family members such as Bak and Bad. Overexpression of Bcl-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer. |
|||
Bcl-2 Antibody |
|||
3337-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Bcl-2 Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Bcl-2 is the founding member of a family of over 20 proteins that are critical regulators of apoptosis. These can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bcl-2 is an inner mitochondrial membrane protein that inhibits apoptosis. It is thought to act by interacting with pro-apoptotic Bcl-2 family members such as Bak and Bad. Overexpression of Bcl-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer. |
|||
BCL- 2 Antibody |
|||
ABF0769 | Lifescience Market | 100 ug | 525.6 EUR |
BCL- 2 Antibody |
|||
ABF6139 | Lifescience Market | 100 ug | 525.6 EUR |
Bcl- 2 Antibody |
|||
ABD6014 | Lifescience Market | 100 ug | 525.6 EUR |
Bcl-2 Antibody |
|||
R30004 | NSJ Bioreagents | 100 ug | 419 EUR |
Bcl-2 Antibody |
|||
R30105 | NSJ Bioreagents | 100 ug | 419 EUR |
Bcl-2 Antibody |
|||
R32992 | NSJ Bioreagents | 100 ug | 419 EUR |
Bcl-2 Antibody |
|||
RQ5323 | NSJ Bioreagents | 100ul | 419 EUR |
Bcl-2 Antibody |
|||
RQ5324 | NSJ Bioreagents | 100ul | 419 EUR |
Bcl-2 Antibody |
|||
F47422-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Bcl-2 Antibody |
|||
F47422-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Bcl-2 Antibody |
|||
F47585-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
BCL-2 Antibody |
|||
F47585-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Bcl-2 Antibody |
|||
F52104-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Bcl-2 Antibody |
|||
F52104-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Bcl-2 Antibody |
|||
F42666-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Bcl-2 Antibody |
|||
F42666-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Bcl-2 Antibody |
|||
F43285-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Bcl-2 Antibody |
|||
V2007-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of the protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, Bcl-2 antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 and the small number in which the neoplastic cells are negative. |
|||
Bcl-2 Antibody |
|||
V2007-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of the protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, Bcl-2 antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 and the small number in which the neoplastic cells are negative. |
|||
Bcl-2 Antibody |
|||
V2007IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of the protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, Bcl-2 antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 and the small number in which the neoplastic cells are negative. |
|||
Bcl-2 Antibody |
|||
V2007SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of the protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, Bcl-2 antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 and the small number in which the neoplastic cells are negative. |
|||
Bcl-2 Antibody |
|||
V2008-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2008-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2008IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2008SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2009-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2009-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2009IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2009SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of Bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express Bcl-2 protein and the small number in which the neoplastic cells are Bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2833-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2833-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2833IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2833SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2834-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2834-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2834IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V2834SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3542-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3542-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3542IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3542SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3543-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. |
|||
Bcl-2 Antibody |
|||
V3543-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. |
|||
Bcl-2 Antibody |
|||
V3543IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. |
|||
Bcl-2 Antibody |
|||
V3543SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. |
|||
Bcl-2 Antibody |
|||
V3546-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. |
|||
Bcl-2 Antibody |
|||
V3546-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. |
|||
Bcl-2 Antibody |
|||
V3546IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. |
|||
Bcl-2 Antibody |
|||
V3546SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. |
|||
Bcl-2 Antibody |
|||
V3547-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3547-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3547IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3547SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3671-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3671-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V3671SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V7145-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Bcl2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release. [UniProt] |
|||
Bcl-2 Antibody |
|||
V7145-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Bcl2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release. [UniProt] |
|||
Bcl-2 Antibody |
|||
V7145IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Bcl2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release. [UniProt] |
|||
Bcl-2 Antibody |
|||
V7145SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Bcl2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release. [UniProt] |
|||
Bcl-2 Antibody |
|||
V8837-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V8837-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V8837SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V8937-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V8937-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V8937SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9074-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9074-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9074IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9074SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the Bcl-2 alpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9288-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression ofbcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9288-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression ofbcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
V9288SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: This antibody recognizes a protein of 25-26kDa, identified as the bcl-2 lpha oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression ofbcl-2 lpha oncoprotein inhibits the programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 lpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative. |
|||
Bcl-2 Antibody |
|||
3033-100 | Biovision | each | 438 EUR |
Bcl-2 Antibody |
|||
3033-30T | Biovision | each | 175.2 EUR |
Bcl-2 (phospho Ser70) Polyclonal Antibody |
|||
ABP53388-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of Bcl-2 phospho Ser70) from Mouse, Rat. This Bcl-2 phospho Ser70) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the phosphorylation site of S70 |
|||
Bcl-2 (phospho Ser70) Polyclonal Antibody |
|||
ABP53388-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 phospho Ser70) from Mouse, Rat. This Bcl-2 phospho Ser70) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the phosphorylation site of S70 |
|||
Bcl-2 (phospho Ser70) Polyclonal Antibody |
|||
ABP53388-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of Bcl-2 phospho Ser70) from Mouse, Rat. This Bcl-2 phospho Ser70) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcl-2 around the phosphorylation site of S70 |
|||
Bcl-2 (phospho Thr69) Polyclonal Antibody |
|||
ES7019-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Thr69) from Human. This antibody is tested and validated for IHC, IF, WB, ELISA |
|||
Bcl-2 (phospho Thr69) Polyclonal Antibody |
|||
ES7019-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Thr69) from Human. This antibody is tested and validated for IHC, IF, WB, ELISA |
|||
Bcl-2 (phospho Ser87) Polyclonal Antibody |
|||
ES7020-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Ser87) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 (phospho Ser87) Polyclonal Antibody |
|||
ES7020-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Ser87) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Bcl-2 (phospho Thr74) Polyclonal Antibody |
|||
ES7021-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Thr74) from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
Bcl-2 (phospho Thr74) Polyclonal Antibody |
|||
ES7021-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Thr74) from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
Bcl-2 (phospho Ser70) Polyclonal Antibody |
|||
ES1272-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Ser70) from Human/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IP, WB, ELISA |
|||
Bcl-2 (phospho Ser70) Polyclonal Antibody |
|||
ES1272-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Ser70) from Human/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IP, WB, ELISA |
|||
Bcl-2 (phospho Thr56) Polyclonal Antibody |
|||
ES1273-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against Bcl-2 (phospho Thr56) from Human. This antibody is tested and validated for WB, ELISA, IHC, IP, IF, WB, ELISA |